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The field of systems biology is often held back by difficulties in obtaining comprehensive, high-
quality, quantitative data sets. In this paper, we undertook an interlaboratory effort to generate 
such a data set for a very large number of cellular components in the yeast Saccharomyces 
cerevisiae, a widely used model organism that is also used in the production of fuels, chemicals, 
food ingredients and pharmaceuticals. With the current focus on biofuels and sustainability, 
there is much interest in harnessing this species as a general cell factory. In this study, we 
characterized two yeast strains, under two standard growth conditions. We ensured the 
high quality of the experimental data by evaluating a wide range of sampling and analytical 
techniques. Here we show significant differences in the maximum specific growth rate and 
biomass yield between the two strains. on the basis of the integrated analysis of the high-
throughput data, we hypothesize that differences in phenotype are due to differences in protein 
metabolism. 
1 Department of Biotechnology, Kluyver Centre for Genomics of Industrial Fermentation, Delft University of Technology, Julianalaan 67, Delft 2628 BC, 
The Netherlands. 2 Cambridge Systems Biology Centre & Department of Biochemistry, University of Cambridge, Sanger Building, 80 Tennis Court Road, 
Cambridge CB2 1GA, UK. 3 Department of Systems Biology, Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby DK-2800 
Kgs, Denmark. 4 Department of Chemical and Biological Engineering, Chalmers University of Technology, Goteborg SE-41296, Sweden. 5 VTT Technical 
Research Centre of Finland, PO Box 1000, Espoo FI-02044 VTT, Finland. 6 Department of Molecular Cell Physiology, Vrije Universiteit Amsterdam, De 
Boelelaan 1085, Amsterdam 1081 HV, The Netherlands. 7 Institut für Bioverfahrenstechnik, University of Stuttgart, Allmandring 31, Stuttgart D-70569, 
Germany. 8 Department of Chemical Engineering, Bogazici University, Bebek, Istanbul 34342, Turkey. 9 Institute for Molecular Systems Biology, ETH Zürich, 
Zürich CH-8093, Switzerland. 10 Laboratoire Bordelais de Recherche en Informatique, UMR CNRS 5800, France. *These authors contributed equally to the 
work. Correspondence and requests for materials should be addressed to J.N. (email: nielsenj@chalmers.se). 
Integrated multilaboratory systems biology reveals 
differences in protein metabolism between two 
reference yeast strains
André B. Canelas1,*, nicola Harrison2,*, Alessandro Fazio3,*, Jie Zhang4,*, Juha-Pekka Pitkänen5,  
Joost van den Brink1, Barbara m. Bakker6, Lara Bogner7, Jildau Bouwman6, Juan I. Castrillo2, Ayca Cankorur8, 
Pramote Chumnanpuen4, Pascale Daran-Lapujade1, Duygu Dikicioglu8, Karen van Eunen6, Jennifer C. Ewald9, 
Joseph J. Heijnen1, Betul Kirdar8, Ismo mattila5, Femke I. C. mensonides6, Anja niebel7, merja Penttilä5,  
Jack T. Pronk1, matthias Reuss7, Laura salusjärvi5, uwe sauer9, David sherman10, martin siemann-Herzberg7, 
Hans Westerhoff6, Johannes de Winde1, Dina Petranovic4, stephen G. oliver2, Christopher T. Workman3,  
nicola Zamboni9 & Jens nielsen4
ARTICLE

nATuRE CommunICATIons | DoI: 10.1038/ncomms1150
nATuRE CommunICATIons | 1:145 | DoI: 10.1038/ncomms1150 | www.nature.com/naturecommunications
© 2010 Macmillan Publishers Limited. All rights reserved.
There are many definitions and interpretations of systems biol-ogy, but most involve mathematical modelling, high-through-put (or omics) analysis, mapping of interactions between cel-
lular components and quantification of dynamic responses in living 
cells1–5. In most cases, the objective of systems biology is to obtain 
a quantitative description of the biological system under study, and 
this quantitative description is ideally in the form of a mathematical 
model that can be used to simulate the operations of the biological 
system. Even though some mathematical modelling concepts rely 
only on limited data sets (for example, flux balance analysis), most 
systems biology efforts will require large sets of high-quality experi-
mental data that enable, for example, to discriminate between differ-
ent model structures. Generation of such data is therefore the core 
of many studies that use the systems biology approach. However, the 
infrastructure and expertise needed to generate the large number 
of different data required for advanced systems biology studies (for 
example, transcriptomics, proteomics, metabolomics) is normally 
beyond the capabilities of a single laboratory. Therefore, there is a 
trend towards multilaboratory collaboration projects and the estab-
lishment of curated databases that contain high-quality data sets6. 
To ensure proper documentation of experiments, some effort has 
also been directed at establishing protocol formats, such as MIAME 
(Minimum Information About a Microarray Experiment) for DNA 
array experiments7, MIAPE (Minimum Information About a Pro-
teomics Experiment) and PRIDE (PRoteomics IDEntification) for 
proteome analysis8,9, protocols for microbial metabolome analysis10, 
and even protocols for documentation of mathematical models such 
as MIRIAM11 (Minimum Information Requested In the Annotation 
of biochemical Models). Even though these protocol formats aim 
to ensure proper documentation of the actual experiments, there is 
still a need for consolidation of applied experimental conditions and 
procedures, in order to allow the generation of increasingly large, 
coherent data sets for the same organism or strain that will eventu-
ally represent a rich resource for advanced mathematical modelling 
and contribute to our understanding of the living cell.
In this study, The Yeast Systems Biology Network (YSBN) under-
took a major effort to consolidate and compare experimental condi-
tions, procedures and protocols applied for the experimental part of 
yeast systems biology in 10 different European laboratories, and at 
the same time performed a comparative analysis of different quan-
titative analytical methods. This has resulted in the establishment 
of a well-documented experimental ‘systems biology pipeline’ that 
is illustrated in Figure 1. The ‘pipeline’ allows for the comparison 
of different yeast strains or the comparison of a single yeast strain 
grown under different conditions. In this study, we evaluated the 
‘pipeline’ by comparing two different yeast strains grown under 
two different conditions in biorectors, namely, a traditional batch 
culture (nutrient excess) and a glucose-limited chemostat culture 
(specific growth rate controlled by the rate of supply of the limiting 
nutrient, glucose).
The resulting data set will constitute a valuable reference for fur-
ther studies using these two strains and hence advance the field of 
yeast systems biology. Furthermore, we were able to illustrate how 
comprehensive information on multiple omics levels (for example, 
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Figure 1 | Overview of the systems biology pipeline used in this study. Two yeast strains were compared: YsBn2, a newly constructed prototrophic 
strain closely related to the originally sequenced s288c strain, and CEn.PK113-7D, a widely used reference strain for physiological studies and industrial 
applications. Each strain was grown in well-controlled bioreactors under both substrate excess (batch) and substrate-limited growth conditions 
(chemostat), each in triplicate, at a single location. A fast sampling sequence and parallel processing allowed the reliable and reproducible generation 
of the necessary material for multiplexed omics analyses. samples were shipped to the different laboratories involved in this project for analysis of the 
transcriptome, the metabolome and the activity key enzymes, each using multiple platforms/techniques. The data obtained were collected and integrated, 
resulting in a very thorough phenotypic characterization of the two strains. qPCR: quantitative-PCR; TRAC: TRanscript analysis with Affinity Capture; 
HPLC: high-performance liquid chromatography; ms: mass spectrometry; LC: liquid chromatography; GC: gas chromatography; ToF: time-of-flight mass 
spectrometry; DAD: diode array detection.
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fluxes, transcripts and metabolites) can be used collectively to gen-
erate hypotheses that would not arise from their individual analysis. 
Specifically, the integrated analysis of our data set pointed to differ-
ences in the regulation of protein metabolism as the source of the 
pronounced physiological differences observed (maximum specific 
growth rate and biomass yield on substrate) between the two strains 
investigated.
Results
Construction of a new set of reference S. cerevisiae strains. The 
first step in the establishment of our experimental systems biology 
pipeline was to find appropriate yeast strains that would be of 
interest. In the yeast community, a range of different yeast strains 
are being used, with the strain series BY, W303 and CEN.PK being 
the most frequently used12. The BY strain series is a derivative of 
the originally sequenced strain S288c, for which there is a complete 
gene knockout collection. The CEN.PK strain series is used widely 
in physiological studies and, because of its rapid growth, is also 
often used for metabolic engineering studies12. Physiological studies 
are generally best performed with prototrophic strains, whereas the 
BY series strains carry a number of auxotrophies that may cause 
problems for quantitative studies of cellular physiology. Hence, there 
was a need to generate prototrophic strains in the S288c background 
that nonetheless carried some genetic markers that would permit 
checks against contamination, in large-scale or long-term cultures, 
and facilitate subsequent genetic crosses (for instance, of evolved 
derivatives). For this reason, two diploid strains, YSBN1 and YSBN2, 
were generated from FY1 and FY2, two uracil auxotrophic strains 
that are direct derivatives of S288c (ref. 13). FY2 is the strain from 
which the BY strain series14, and hence the strain from which the 
complete knockout collection15, was derived. YSBN1 and YSBN2 
are prototrophic strains that carry drug resistance markers inserted 
into their genomes at a phenotypically neutral site16,17. Besides the 
two diploid strains, a set of haploid strains with the two different 
mating types was also constructed (Supplementary Table S1). All 
the strains are available from EUROSCARF (web.uni-frankfurt.de/
fb15/mikro/euroscarf/yeast.html).
Comparison of the two strains under two growth conditions. 
To evaluate the newly constructed strain, we performed a detailed 
comparative analysis of the YSBN2 strain with the widely used 
strain CEN.PK113-7D. Each strain was grown in batch cultures, 
which were sampled in the mid-exponential growth phase (on 
glucose) (Supplementary Fig. S1). After the diauxic shift and the 
ethanol growth phase, the cultures were used to initiate chemo-
stat cultivations, which were sampled after steady-state conditions 
were achieved (Supplementary Fig. S2). Fermentations were carried 
out in triplicate with each strain and each condition, resulting in 
a total of 12 samples. The detailed cultivation protocols are given 
as Supplementary Methods. The experiments were conducted in 
well-controlled bioreactors in a single laboratory, which ensured a 
very high degree of reproducibility (Table 1), and samples were then 
shipped to different laboratories for analysis. The key physiological 
parameters of each strain under both conditions are summarized in 
Table 1. From the initial analysis it is interesting to observe that the 
maximum specific growth rate of the CEN.PK strain is significantly 
higher than that of the YSBN strain, by approximately 25%, whereas 
its biomass yield under carbon-limited conditions (chemostat) is 
significantly lower, by approximately 10%. The differences in bio-
mass yield cannot be explained by major differences in the contents 
of total protein or carbohydrate (Supplymentary Note 1). Thus, one 
could speculate whether the ability of CEN.PK to grow faster when 
resources are abundant has come at the expense of efficiency in car-
bon and energy utilization under nutrient limitation.
Our analysis involved sampling for determination of mRNA 
levels, using DNA arrays (Affymetrix and Agilent), quantitative 
PCR (qPCR) and TRAC (TRanscript analysis with Affinity Cap-
ture)18; enzyme activities, using optimized and in vivo-like assays; 
and endometabolome, using several analytical platforms including 
liquid chromatography-mass spectrometry (LC-MS), gas chro-
matography time-of-flight mass spectrometry (GC-TOF), two 
dimensional gas chromatography coupled to time-of-flight mass 
spectrometry (GCxGC-TOF), nuclear magnetic resonance (NMR), 
high-performance liquid chromatography-diode array detection 
(HPLC-DAD) and enzymatic analysis. Table 2 gives an overview of 
the sampling procedure, which was designed taking into account 
the large number of samples needed and the fast turnover of some 
molecules to be analysed (for example, intracellular metabolites). 
Fast sampling and parallel sample processing required a team of five 
people, of whom three carried out the same key steps in all 12 sam-
pling procedures. Detailed protocols of all sampling and processing 
techniques are given in Supplementary Methods.
Combination of omics platforms. Transcripts were measured 
using a range of different methods. Genome-wide analysis was per-
formed using both the Affymetrix and Agilent platforms. qPCR was 
performed in two different laboratories and used to quantify the 
expression of a number of selected genes (Supplementary Table S2 
Table 1 | Overview of physiological parameters for both strains under both growth conditions.
Batch Chemostat
CEN.PK 113-7D YSBN2 CEN.PK 113-7D YSBN2
specific growth rate (h−1) 0.40 ± 0.01 0.301 ± 0.002 0.099 ± 0.001 0.097 ± 0.001
Biomass concentration (g l − 1) 1.9 ± 0.1 1.9 ± 0.2 3.92 ± 0.01 4.35 ± 0.04
Extracellular glucose 
concentration (g l − 1)
17.4 ± 0.6 15 ± 1 0.033 ± 0.002 0.032 ± 0.008
qGluc (mmol gDW − 1 h − 1)  − 16 ± 1  − 13.0 ± 0.5  − 1.043 ± 0.009  − 0.93 ± 0.01
qEth (mmol gDW − 1 h − 1) 23 ± 3 19 ± 3  − 0.165 ± 0.001  − 0.146 ± 0.002
qGlyc (mmol gDW − 1 h − 1) 0.89 ± 0.02 1.19 ± 0.07 nA nA
qo2 (mmol gDW−1 h − 1)  − 2.6 ± 0.3  − 1.06 ± 0.02  − 2.74 ± 0.03  − 2.11 ± 0.04
qCo2 (mmol gDW − 1 h − 1) 26.6 ± 0.1 23 ± 1 2.71 ± 0.02 2.09 ± 0.04
RQ ( − ) 10.1 ± 0.9 21 ± 1 0.990 ± 0.004 0.99 ± 0.01
Ys/x (Cmol Cmol − 1) 0.16 ± 0.01 0.146 ± 0.005 0.568 ± 0.002 0.630 ± 0.006
qH +  (mmol gDW − 1 h − 1)  − 3.1 ± 0.3  − 2.3 ± 0.1 0.65 ± 0.01 0.60 ± 0.02
Carbon balance recovery 94 ± 11% 98 ± 9% 97.9 ± 0.1% 98.7 ± 0.5%
Degree of reduction balance 
recovery
94 ± 15% 96 ± 11% 95.7 ± 0.5% 97.5 ± 0.9%
Data are averages and s.d.s between triplicate cultures. The yield coefficient for biomass is calculated based on a molecular weight for biomass of 26.4 g Cmol − 1 (ref. 30). nA, glycerol was not detectably 
produced under chemostat conditions.
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and Supplementary Fig. S3). TRAC analysis was also performed, as 
it allows for multiplex detection of mRNA targets simultaneously 
from a large number of samples (Supplementary Fig. S4). Compari-
son of mRNA levels determined in four different laboratories using 
the four different analytical methods shows a good overall consist-
ency (Fig. 2). qPCR analysis performed in one of the laboratories 
was used to check the consistency of 33 genes that were found to 
have significantly changed expression on the basis of an analysis 
of variance of the Affymetrix data. This analysis shows very clearly 
that, when high-quality platforms for genome-wide transcription 
analysis are used, one obtains equally quantitative information as by 
qPCR (Supplementary Table S3), both in terms of significance and 
changes in expression levels (Fig. 2). The TRAC analysis also showed 
a fairly good consistency with DNA array data, but about 15% of 
the analysed transcripts had a very poor correlation, on the basis 
of analysis of the four different samples (2 strains × 2 conditions), 
and another 15% had a Pearson’s correlation coefficient  < 0.85 (Sup-
plementary Table S4). We did not find a linear correlation between 
the Affymetrix and Agilent data (Fig. 2, Supplementary Figs S5 and 
S6), but this can be explained by the use of a different dynamic scan-
ning range by the Agilent scanner. However, the significant genes 
identified by analysis of variance using the two platforms were 
fairly consistent; that is, out of a total of 410 transcripts found to 
be significantly changed in response to growth conditions (includ-
ing both strains and both array platforms), 241 transcripts were 
found consistently by both platforms (Supplementary Figs S5, S7 
and S8). Thus, we conclude that both platforms are equally strong; 
however, in light of the large data sets that are already available with 
the Affymetrix, we recommend the use of this platform, as this will 
allow for further expansion of the already large database of Affyme-
trix-based transcriptome data.
We also measured the activity levels of key glycolytic enzymes 
in cell extracts. Measurements taken in two different laboratories 
yield a good overall consistency in the data (Supplementary Fig. 
S9, Supplementary Data 1). In connection with the experiment, we 
also evaluated a new approach to quantify enzyme activities using 
assay conditions designed to better represent in vivo-like conditions 
(where the assay medium is designed to mimic the actual intracel-
lular environment, see Methods and Supplementary Methods), as 
opposed to the typical approach of using optimal conditions for 
each enzyme (Fig. 3)19. We found that with the in vivo-like assays the 
range of enzyme activities was in the same order of magnitude as the 
glycolytic flux, which was not observed using traditional analysis of 
glycolytic enzyme activities.
Metabolome samples were analysed independently by seven par-
ticipating laboratories according to their own standard operating 
procedures (see Supplementary Methods for detailed description). 
Four variations in extraction protocol, five analytical platforms 
(LC-MS, GC-TOF, GCxGC-TOF, enzymatic, HPLC-DAD) and three 
internal standard strategies were used in different combinations. 
The interlaboratory comparison shows that absolute concentration 
estimates from different laboratories can vary by up to threefold, 
even for identical sample processing (see Supplementary Note 2, 
Supplementary Data 2). However, when comparing only the relative 
concentration differences between growth conditions or strains, all 
laboratories deliver a surprisingly consistent picture. Furthermore, 
relevant metabolite ratios (for example, mass-action ratios) based 
on measurements from different laboratories were comparable. As 
redundancy was obtained with heterogeneous preparation protocols 
and orthogonal analytical methods, we conclude that, even with the 
current state-of-the-art metabolomics, ratiometric measurements 
still have much higher reliability than do absolute estimates.
Integrated analysis. Integrated data analysis started by consider-
ing the exo-metabolome data, which provided information about 
the ‘gross phenotype’. Through measurements of all key nutrients 
and metabolites being secreted or released into the medium (including 
Table 2 | Sequence of sampling for the different ‘omics’ analyses.
Turnover Target molecules Quenching Sample number 
and volume (ml)
Total volume withdrawn 
(including waste) (ml)
Duration 
(min)
Notes
Fastest Intracellular 
metabolites
In cold methanol 
(≤ − 40 °C)
12×1  
8×5
~80 ~2 Volume withdrawn not 
sufficient to perturb 
chemostat steady state
mRnA In liquid nitrogen 1×300–500 300–500  < 1
mRnA and proteins 
sampled in  < 2 min. Total 
time ~4 minslowest Enzyme activities on ice 4×20 ~150  < 1
The order and timing were designed taking into consideration the differences in turnover of the different analytes and the need to obtain a coherent ‘snapshot’ of metabolism. The procedure provided  
sufficient material for all analyses while preventing unwanted changes due to perturbation of the culture.
TRAC
0.076
0.14
0.056
0.07 0.62
0.61
0.64
qPCR
(BU)
qPCR
(VUA)
0.47
0.53 0.91
Microarray
(affymetrix)
Microarray
(agilent)
Figure 2 | Correlation analysis of the different platforms used for mRNA. 
The correlation matrix shows how the different analytical platforms 
correlate with respect to measurement of mRnA. The correlation between 
each pair of platforms is shown both as data in a black box (the upper right 
corner) and the Pearson’s correlation coefficient in a red box (the lower 
left corner), which are in the corresponding row and column as the pair of 
platforms compared (the diagonal of the matrix).
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analysis of the gas phase), it was possible to obtain very precise 
measurements of the overall metabolic fluxes, and these are summa-
rized in Figure 4. Under substrate-excess growth conditions (batch 
cultivation), it was observed that the CEN.PK113-7D strain exhib-
ited a  > 20% higher glucose uptake rate, which was accompanied by 
a higher flux towards ethanol. The specific carbon dioxide produc-
tion not associated with ethanol production was the same in the two 
strains, despite the fact that the specific oxygen uptake rate was more 
than twofold higher in the CEN.PK113-7D strain compared with 
the YSBN2 strain. This suggests that the higher oxygen uptake rate 
allowed for a reduced glycerol production by the CEN.PK113-7D 
strain, as overflow towards glycerol production under fermentative 
growth conditions serves as an alternative NADH sink. The higher 
glycolytic flux in the CEN.PK113-7D strain at substrate excess 
growth conditions (batch) is not associated with increased activities 
of glycolytic enzymes (see Fig. 3) or large differences in the levels of 
glycolytic intermediates (Fig. 4b). For practically all of the glycolytic 
enzymes, there was a higher activity in the YSBN2 strain compared 
with the CEN.PK113-7D strain (results were confirmed by meas-
urements in two independent laboratories, see Supplementary Fig. 
S9). In the comparison between growth conditions, the higher gly-
colytic flux in batch culture compared with that in the chemostat is 
associated with higher enzyme activities for practically all glycolytic 
enzymes in both strains. However, as the enzyme activity level was 
only about 50% lower in the chemostat compared with the batch 
cultures, it is clear that enzyme activities cannot alone describe the 
almost 10-fold lower glycolytic flux in the chemostat. This indicates 
that the adjustment of the glycolytic flux to fermentative conditions 
is to a large extent determined by changes in the levels of meta-
bolic intermediates and effectors; that is, flux control is primarily 
at the metabolic level. This finding is consistent with earlier more 
detailed studies on glycolysis18–22. The metabolome data, however, 
do not provide any insight into the differences in fluxes between the 
two strains, as there are very small differences in metabolite levels 
between the different strains, and most differences indicate slightly 
higher metabolite concentrations in the YSBN2 strain, which has 
lower fluxes. Finally, the higher activity of glycolytic enzymes 
in the batch cultures is associated with increased expression of 
several glycolytic genes (PFK1, TPI1, ENO2, TDH2, TDH3, PYK1, 
PDC1, ADH1; Supplementary Fig. S3). However, the slightly higher 
enzyme activities found in the YSBN2 strain (compared with CEN.
PK113-7D) are not associated with higher expression of the respec-
tive genes.
Although there is no direct correlation between fluxes, enzyme 
activities and intracellular metabolite levels, it is striking that under 
batch conditions the levels of practically all amino acids were 
noticeably higher in CEN.PK113-7D than in the YSBN2 strain. 
This led us to perform a more detailed analysis of the gene expres-
sion data. Using methods for integrative analysis23,24, we calculated 
enriched gene ontology (GO) terms for transcripts differing signifi-
cantly between the two strains at both growth conditions, as well 
as for reporter metabolites24 and reporter transcription factors25. 
These methods allow for identification of transcriptional hotspots 
in metabolic networks, that is, metabolites around which there are 
large transcriptional changes, and transcription factors (TFs) that 
drive key transcriptional responses. The results of this analysis are 
shown in Table 3 and Supplementary Tables S5–S10. In Table 3, 
representative GO terms indicate sets of genes that had significant 
differences in expression between the two strains. Reporter metabo-
lites indicate locations in metabolism around which there are large 
transcriptional differences, and reporter TFs indicate TFs for which 
there are significant changes in expression of associated genes. For 
batch cultures, the analysis points to a clear effect on amino-acid 
transport, with several amino-acid transporter genes being differ-
entially expressed between the two strains (most transporters being 
expressed at a higher level in YSBN2). Further, there is a distinct 
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Figure 3 | Measurements of enzyme activities using an in vivo-like 
assay for the two strains grown at the two different conditions. Bars 
show enzyme activities for the different enzymes in the glycolysis. Error 
bars show sEm based on three biological replicates. Dark blue: YsBn 
strain in batch; dark red: CEn.PK strain in batch; light blue: YsBn strain 
in chemostat; light red: CEn.PK strain in chemostat. HXK: hexokinase; 
PGI: phosphoglucose isomerase; PFK: phosphofructokinase; ALD: alanine 
dehydrogenase; TPI: triosephosphate isomerase; GAPDH: Glyceraldehyde 
3-phosphate dehydrogenase; PGK: Phosphoglycerate kinase; GPm:  
3-phosphoglycerate mutase; Eno: enolase; PYK: pyruvate kinase; PDG: 
pyruvate decarboxylase; ADH: alcohol dehydrogenase.
Batch
–3 5
Metabolome data CEN.PK YSBN2
Glucose 6.76 8.04
Glucose 6-P 0.59 1.05
Fructose 6-P –0.20 0.38
Fructose 1,6-bisP 4.92 5.50
Dihydroxyacetone-P 2.85 3.49
Glycerol 3-P 2.73 3.61
2,3-Bis-P-glycerate 0.41 –0.27Chemostat
3-P-glycerate –1.91 –3.07
2/3-P-glycerate –1.75 –2.63
Phosphoenolpyruvate –2.36 –2.67
Pyruvate 4.16 4.46
Lactate 2.49 3.85
Glc
G3P
Pyr
Gly
EtOH + CO2
CO2
0.93/1.04
0.146/0.165
2.09/2.73
0/0
Glc
G3P
Pyr
Gly
EtOH + CO2
CO2
13/16
19/23
4.0/3.6
1.2/0.9
Figure 4 | Overall fluxes and concentration changes for glycolytic 
metabolites in strains CEN.PK113-7D and YSBN2 in batch and chemostat 
cultivations. (a) From measurements of the concentrations of biomass, 
glucose, ethanol and glycerol in the medium and of carbon dioxide and 
oxygen in the exhaust gas, the overall exchange rates can be calculated. 
The CEn.PK113-7D strain (blue data) has a higher glucose uptake rate, a 
higher flux towards ethanol and a higher oxygen uptake rate, whereas the 
carbon dioxide production rate is about the same for the two strains (the 
flux towards Co2 is corrected for the amount of Co2 formed in relation to 
ethanol production). The YsBn2 strain (red data) has a higher glycerol 
production rate in the batch fermentation. In the chemostat culture, 
the biomass yield is higher for the YsBn2 strain (red data) and this is 
accompanied by higher specific fluxes in the CEn.PK113-7D strain.  
(b) measurement of glycolytic metabolites, in which it is found that for 
both strains there is an increase in most of the glycolytic metabolites in the 
batch culture compared with the chemostat (red bars indicate increased 
metabolite levels). numbers are log2 values of the ratio between batch and 
chemostat levels.
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nitrogen catabolite repression response in the YSBN2 strain in the 
batch culture, with Gln3p and Gat1p being identified as reporter 
TFs, that is, TFs that control a set of genes that have significant tran-
scriptional changes. Thus, there are clearly differences in how the 
two strains control amino-acid biosynthesis. YSBN2 expresses many 
amino-acid transporters even when growing on minimal medium 
(without amino-acid supplementation) and CEN.PK113-7D is able 
to maintain higher intracellular amino-acid pools. The latter may 
be important for ensuring efficient loading of the tRNAs needed for 
protein biosynthesis, which in turn could be the basic explanation 
for the higher specific growth rate of CEN.PK113-7D.
Discussion
The molecular explanation for the higher glucose uptake of CEN.
PK113-7D and the differences in overall fluxes through the central 
carbon metabolism between the two strains has not been identi-
fied yet. As mentioned previously, several studies have shown that 
there is complex regulation of the glycolytic flux, and that overex-
pression of glycolytic genes in yeast does not result in an increased 
flux through this pathway26,27. We hypothesize that the higher glu-
cose uptake of CEN.PK113-7D could arise from the differences in 
protein biosynthesis in the two strains. Protein synthesis is costly 
in terms of Gibbs-free energy provided in the form of adenosine 
triphosphate (ATP), and the increased glycolytic flux in the CEN.
PK113-7D strain could arise from a pull of ATP and other cofactors 
needed for biomass production. Changes in protein biosynthesis, 
protein catabolism and proteolysis in the two strains could also 
explain the lower biomass yield of CEN.PK113-7D in chemostat 
culture compared with the YSBN2 strain. We find GO terms on pro-
tein catabolism and proteolysis and a large number of genes associ-
ated with these terms were significantly more highly expressed in 
the CEN.PK113-7D strain compared with the YSBN2 strain. This 
is clearly linked to the TF Rpn4, which regulates the 26S proteo-
some. This indication of increased protein turnover in CEN.PK113-
7D is also consistent with our finding of a Gcn4 response in that 
strain. Gcn4 is a TF that positively regulates the transcription of 
a large number of genes that encode for amino-acid biosynthetic 
enzymes. In fact, a large number of these genes are also identi-
fied as being significantly more highly expressed in CEN.PK113-
7D compared with YSBN2. Taken together, these observations 
strongly point to higher amino-acid and protein biosynthesis, as 
well as to increased protein degradation in CEN.PK113-7D (Fig. 5). 
As amino-acid synthesis and polymerization represent the most 
energetically costly process in biomass formation, a higher rate 
of protein turnover in the CEN.PK113-7D strain could certainly 
explain the lower biomass yield. This provides a molecular hypo-
thesis for the general statement made above; the CEN.PK113-7D 
strain has a more effective machinery for rapid protein biosynthesis 
and it can thereby grow faster, but the effect of this is a less-efficient 
utilization of the carbon and energy source under growth-limiting 
conditions. This is consistent with a thermodynamic analysis of 
microbial growth, where it is found that there is a trade-off between 
Table 3 | Overview of main transcriptome analysis results obtained from the comparison between CEN.PK113-7D and YSBN2 
strains.
Batch Chemostat
GO terms Reporter 
metabolite
Reporter TF ORFs GO term Reporter 
metabolite
Reporter TF ORFs
Response to 
pheromone
CBK1, FUS3 FUS3, FUS1, STE5, 
MFA1, STE2, AGA2, 
BAR1, PRM10, FAR1, 
STE18, SST2, STE4
Protein 
catabolism
RPN4 PIM1, PRE7, VID24, UMP1, RPN6, 
CDC48, RPT3, RPN9, RAD23, PRB1, 
RPN11, PRE4, SCL1, RPT6, UFD1, 
PUP2, ECM29, RPN1, PRE3, UBX6, 
LAP4, PRE8, PRE5, YDJ1, PUP1, 
RPT4, RPN8, PRE2, RPN7, SUE1
sterol 
biosynthesis
(R)-
mevalonate, 
Episterol
MOT3 ERG28, ERG26, 
ERG3, HMG1, ERG13, 
ERG2, CYB5, MVD1
Amino-acid 
biosynthesis
Cys, Gly, Asn, 
Leu
GCN4 TRP4, SAM2, GLY1, HIS1, ARG5,6, 
AGX1, MET13, STR3, SER2, ARG3, 
BAT2, ALT1, PUT1, SAM1, ECM40, 
LEU4, ARG1, ARG8, LEU9, ASN1
Amino-acid 
transport
Leu, Phe, Ile, 
Val, Tyr, ALAxt, 
Asn, GLnxt, 
Cys, mETxt, 
Trp, Gly,THRxt, 
PRoxt, HIsxt
GLN3, GAT1 BAP3, CAN1, AGP2, 
BAP2, PUT4, SAM3, 
DIP5, AGP1, GAP1
Heterocycle 
metabolism
URA7, HEM12, TRP4, ARO10, 
ADE8, SAM2, HEM2, SDT1, ADE5,7, 
PDC6, MTD1, SAM1, HMX1, ADH6, 
AAH1, BIO3, ADE2, COX10
Proteolysis RPN4 PIM1, PRE7, VID24, UMP1, PRD1, 
RPN6, CDC48, RPT3, RPN9, RAD23, 
RPN11, PRE4, SCL1, RPT6, UFD1, 
PHB2, PUP2, RPN1, PRE3, UBX6, 
PRE8, YTA12, PRE5, YDJ1, PUP1, 
RPT4, RPN8, PRE2, RPN7
Trehalose 
metabolism
α,α′-Trehalose 
6-P, α,α-
Trehalose
TPS2 NTH1, TPS2, UGP1, 
TSL1, PGM2
sterol 
biosynthesis
5-Diphospho 
mevalonate
ERG26, ERG25, ERG1, NCP1, ERG7, 
ERG9, ERG27, ERG6, HMG1, ERG13, 
ERG5, ERG2, ERG12, ERG8, CYB5, 
NSG2, ERG24, MVD1, ERG20
Allantoin 
metabolism
Allantoin DUR1,2, DAL1, DAL4, DAL2, 
DAL7, DAL3
Cytokinesis CBK1 BOI2, DSE1, SCW11, MYO1, DSE2, 
CTS1, DSE4
Abbreviation: oRF, open reading frame.
Representative Go terms, reporter metabolites, reporter TF and oRFs that were significantly changed between the two strains in the two growth conditions are presented (in bold text, those being 
expressed higher in the YsBn2 strain relative to CEn.PK; in normal text, those being expressed lower). Addition of xt marks that only the extracellular amino acid was identified as a reporter metabolite 
(otherwise, both the intra- and extracellular pools were identified).
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the Gibbs-free energy dissipation as a driving force for growth and 
biomass yield28. The changes oberved in the CEN.PK113-7D strain 
are summarized in Figure 5, in which it is illustrated that increased 
activity of protein catabolism and proteolysis results in the forma-
tion of a futile cycle in which there is a net consumption of ATP, and 
this imposes a requirement for increased catabolism and respiration 
that ensures the supply of ATP.
Finally, it can be mentioned that we observed, under both growth 
conditions, higher expression levels of genes involved in sterol bio-
synthesis in CEN.PK113-7D than in YSBN2. This is consistent with 
findings that the level of ergosterol is significantly higher in CEN.
PK113-7D than in the S288c strain, to which the YSBN2 strain is 
closely related29.
In conclusion, we demonstrate that through integrative analysis 
of comprehensive data sets it is possible to suggest molecular expla-
nations for observed phenotypes, which would not be possible from 
a single omics data set. Thus, systems biology analysis can be used 
to provide a hypothesis for differences in gross phenotypes such 
as growth rate and biomass yield on glucose, and through follow-
up studies in which specific molecular processes are analysed, the 
provided hypothesis can be evaluated, resulting in novel biological 
insight. Furthermore, our interlaboratory comparison of different 
methods and the detailed protocols provided allows to implement 
the appropriate analytical platform in connection with systems 
biological studies of yeast in different laboratories. Finally, we are 
confident that our interlaboratory comparison of different experi-
mental methods for omics analysis provides very useful reference 
data sets for two yeast strains, and these reference data sets will 
allow further advancement of yeast systems biology. This holds par-
ticularly in connection with further use of the newly constructed 
YSBN strains that represent a valuable resource for the yeast sys-
tems biology community as they are prototrophic (thus suitable 
for physiological studies) and yet closely related to the widely used 
BY-strain series.
Methods
Strains. A set of new reference strains was constructed, on the basis of an S288c 
background, which are prototrophic and carry drug resistance markers. Haploid 
strains were derived from FY2 (MATa ura3-52) and FY3 (MATa ura3-52) (ref. 13) 
by insertion of antibiotic resistance cassettes and a functional URA3 gene. Diploid 
strains were obtained by crossing of the haploids. Details on strain construction 
are provided in Supplementary Methods. For the fermentation experiments we 
used the diploid YSBN2 (hoBle/hoHphMX4) and the commonly used reference 
strain CEN.PK113-7D (ref. 12).
Medium and cultivation conditions. Each strain was grown in triplicate. The six 
fermentations were carried out at Delft University of Technology (TUD) from a 
single batch of defined minimal medium, with 7.5 g l − 1 glucose and 0.3 g l − 1 ethanol 
as carbon sources (the latter to prevent oscillations in the chemostat phase). 
Before inoculation of fermentors, the medium was supplemented with glucose 
for an initial concentration of 30 g l − 1. Cultivations were carried out under aerobic 
conditions, in bioreactors equipped with continuous data acquisition (Applikon; B. 
Braun Biotech), at 30 °C, pH 5.0, with a working volume of 4 l, 0.3 bar overpressure, 
an aeration rate of 0.5 v.v.m. (120 l h − 1) and a stirrer speed of 500 r.p.m. The batch 
cultures were sampled in exponential glucose-consumption phase. Glucose-limited 
chemostat cultures were initiated at the end of the batch phase, carried out at a 
dilution rate of 0.1 h − 1 and sampled after at least five residence times of constant 
dissolved oxygen and off-gas readings. Further details on medium preparation and 
the fermentation protocol are provided in Supplementary Methods.
Sampling sequence and processing. In total, 12 ‘omics’ sampling procedures 
were performed, each resulting in over 40 samples. Each type of sample was 
obtained according to a rapid and well-defined sequence lasting  < 4 min. This 
provided material for all analyses while preventing unwanted changes induced by 
perturbation of the cultivation (see Supplementary Methods). Samples for metabo-
lomics were withdrawn using a custom-made low dead-volume rapid sampling 
setup30. Replicate samples were processed according to the standard procedures in 
use at each laboratory, resulting in seven protocol variations, although all involved 
cold methanol quenching31 and boiling ethanol extraction32 as the key steps, fol-
lowed by evaporation to dryness before distribution. Samples for transcriptomics 
were collected by overpressure and quenched in liquid nitrogen. After thawing and 
washing, the samples were extracted in acidic phenol/chloroform33 before distribu-
tion. Samples for enzyme activity assays were collected by overpressure, quenched 
on ice and washed in potassium buffer before freezing and distribution23. Detailed 
descriptions of all sample processing protocols are provided as Supplementary 
Methods. All samples were shipped to the other laboratories on dry ice by over-
night courier.
Transcriptome analysis. Transcriptomics analyses were carried out at four labora-
tories using four different platforms. Gene expression analysis was performed using 
both Affymetrix (Yeast Genome 2.0) and Agilent (on Agilent 4 × 44 K) microarray 
technologies performed at Technical University of Denmark (DTU). The same 12 
samples (two strains, two conditions in triplicate) were analysed by both methods. 
Data are available at Gene Expression Omnibus with accession number GSE24234. 
Data analysis for each platform was performed independently with the Bioconduc-
tor package (www.bioconductor.org) for the R programming environment (cran.
r-project.org). A subset of about 40 genes (selected on the basis of results from 
microarray analysis) were measured using quantitative reverse transcription PCR 
(qRT–PCR) at Vrije Universiteit Amsterdam (VUA) and Bogazici University (BU), 
as well as by TRanscript analysis with the aid of the Affinity Capture (TRAC) 
method18 at VTT Technical Research Centre of Finland (VTT). Five housekeeping 
genes (TOA2, IPP1, PDA1, PDI1 and SHE10) were carefully chosen and pooled 
as the reference in the qPCR analysis. All primers were designed, checked by in 
silico PCR, and PCR for product specificity and the annealing temperature was 
optimized for the pool of primers. The transciptome data from the two microarray 
platforms, together with transcript levels measured using qPCR and TRAC, were 
compared with each other, and Pearson’s correlation coefficient was calculated 
between each pair of data sets to validate the results and evaluate the comparability 
of data generated in different laboratories using different techniques.
Enzyme activity analysis. Enzyme activities were determined at TUD and VUA. 
Furthermore, measurements at VUA were taken using two different protocols. Cell-
free extracts were prepared from washed samples by bead-beating with acid-washed 
glass beads (425–600 microns, Sigma) in a Qbiogene a Qbiogene FastPrep (MP Bio-
medicals), followed by removal of debris by centrifugation (36,000 g, 4 °C, 20 min). 
Enzyme activities were determined spectrophotometrically in freshly prepared 
extracts by NAD(P)H-linked assays in either a Novostar, BMG Labtech (VUA), 
or a TECAN GENios Pro microtiterplate reader (TUD). Standard assays were 
performed according to Jansen et al.34 In addition, the VUA group also measured 
activities under a recently proposed in vivo-like assay medium designed to mimic 
the intracellular environment19. All results are presented in µmol min − 1 mgprotein − 1.
Metabolome analysis. Metabolite analyses were carried out at seven locations: 
Swiss Federal Institute of Technology Zurich (ETH), DTU, TUD, VTT, VUA,  
University of Stuttgart (US) and University of Cambridge (UC). Different comple-
mentary analytical approaches were available at each laboratory, including several 
MS-based platforms (ETH, TUD, DTU, VTT and UC), as well as HPLC-DAD 
(US), nuclear magnetic resonance (UC) and enzymatic assays (VUA). Determina-
tions were made on samples as shipped after resuspension and minimal condition-
ing, such as removal of debris by centrifugation or filtration, followed by any plat-
form-specific sample preparation, such as derivatization. Quantification was based 
on analysis of pure standards by means of different internal standard compounds/
strategies, including Cl-phenylalanine (DTU), norvaline (ETH), U-13C-labelled cell 
extract (TUD, ETH, VTT) and defined mixes of isotopically labelled compounds 
Glucose
Precursor metabolites
Amino acids
Proteins
CO2
Ergosterol
Lipids
ATP NADH
O2 H2O
ATP
ATP
ATP
ATP GCN4
RPN4
Glucose
Catabolism
Respiration
Figure 5 | Summary of key differences between the YSBN2 and CEN.
PK113-7D strains. Differences were observed in the regulation of 
metabolism between the two strains in chemostat culture. Downregulation 
of amino-acid biosynthesis, protein catabolism and proteolysis in the 
YsBn2 strain via GCn4 and RPn4 is indicated in bold blue lines. A lower 
requirement of ATP for biomass formation is associated with lower specific 
rates of catabolism and respiration, indicated in thin blue lines. This results 
in a higher yield of biomass on substrate for the YsBn2 strain.
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(VTT, UC). Each analytical method is described in detail in the Supplementary 
Methods. Intracellular metabolite levels are presented as µmol gDW − 1.
Integrated data analysis. The representative GO terms were identified using 
hypergeometric tests on the genes that had significant differences in expression for 
the two strains. The reporter metabolites, calculated using the algorithm of Patil 
and Nielsen24, indicate locations in the metabolism around which there are large 
transcriptional differences between the two strains. The reporter TFs, calculated 
using the algorithm of Oliveira et al.25, indicate TFs for which there are significant 
changes in the expression of the genes they are controlling. 
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